Rhinofacial conidiobolomycosis in an immunocompetent 30-year-old male: A case report

Abstract

Rationale: Fungal rhinosinusitis is a rare entity in immunocompetent patients and is a diagnostic challenge. Conidiobolomycosis is a rare cause of fungal rhinosinusitis which happens to affect immunocompetent patients. Patient concerns: A 30-year-old male patient complained of painless progressive swelling of nose for 5 years and painless progressive swelling of upper lip for 4 years associated with nasal obstruction for 5 years. Diagnosis: Rhinofacial conidiobolomycosis. Interventions: Systemic anti-fungals and saturated solution of potassium iodide. Outcomes: Swelling initially reduced but again increased eventually as he discontinued treatment. Lessons: Proper adherence to drugs and need for facial reconstructive surgery may need to be considered in such cases of conidiobolomycosis.

Keywords

Conidiobolomycosis / Fungus / Rhinosinusitis / Tropical / Rhino facial / Entomophthoramycosis

References

[1] El-Shabrawi MH, Arnaout H, Madkour L, Kamal NM. Entomophthoromycosis: A challenging emerging disease. Mycoses 2014; 57(3):132-137.

[2] Walker SD, Clark RV, King CT, Humphries JE, Lytle LS, Butkus DE. Fatal disseminated Conidiobolus coronatus infection in a renal transplant patient. Am J Clin Pathol 1992; 98:559-564.

[3] Bigliazzi C, Poletti V, Dell’Amore D, Saragoni L, Colby TV. Disseminated basidiobolomycosis in an immunocompetent woman. J Clin Microbiol 2004; 42:1367-1369.

[4] Gugnani HC. Entomophthoromycosis due to Conidiobolus. Eur J Epidemiol 1992; 8:391-396.

[5] Gugnani HC. A review of zygomycosis due to Basidiobolus ranarum. Eur J Epidemiol 1999; 15:923-929.

[6] Mugerwa JW. Subcutaneous phycomycosis in Uganda. Br J Dermatol 1976; 94:539-544.

[7] Martinson FD. Clinical, epidemiological and therapeutic aspects of entomophthoromycosis. Ann Soc Belg Med Trop 1972; 52:329-342.

[8] Guarro J, Aguilar C, Pujol I. In-vitro antifungal susceptibilities of Basidiobolus and Conidiobolus spp. strains. J Antimicrob Chemother 1999; 44:557-560.

[9] Gupta M, Narang T, Kaur RJ, Manhas A, Saikia UN, Dogra S. A prospective case series evaluating efficacy and safety of combination of itraconazole and potassium iodide in rhinofacial conidiobolomycosis. Int J Dermatol 2016; 55:208-214.

[10] Blumentrath CG, Grobusch MP, Matsiégui PB, Pahlke F, Zoleko-Manego R, Nzenze-Aféne S, et al. Classification of rhinoentomophthoromycosis into atypical, early, intermediate, and late disease: A proposal. PLoS Negl Trop Dis 2015; 9(10):e0003984. doi: 10.1371/journal.pntd.0003984.